FORTE BIOSCIENCES, INC.

Profile

Company Names

FORTE BIOSCIENCES, INC.
TOCAGEN INC

Addresses

3060 PEGASUS PARK DRIVE, BUILDING 6, DALLAS, TX 75247

3030 BUNKER HILL STREET, SUITE 230, SAN DIEGO, CA 92109

Phone Numbers

(310) 618-6994
(858) 412-8400

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$142,480,240.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2023-07-31 
$25,009,981.00 
$25,009,981.00 
$0.00 
Equity 
9
2016-11-21 
$10,895,750.00 
$13,000,000.00 
$2,104,250.00 
Debt 
8
2013-05-20 
$46,200,326.00 
$50,400,000.00 
$4,199,674.00 
Equity 
7
2012-02-21 
$9,055,340.00 
$15,000,000.00 
$5,944,660.00 
Equity 
6
2010-12-20 
$15,310,930.00 
$28,160,000.00 
$12,849,070.00 
Equity 
5
2010-06-30 
$5,269,000.00 
$12,000,000.00 
$6,731,000.00 
Equity 
4
2010-02-02 
$7,776,750.00 
$8,000,000.00 
$223,250.00 
Equity 
3
2010-01-27 
$3,000,001.00 
$3,000,001.00 
$0.00 
Equity 
2
2009-06-12 
$9,116,162.00 
$10,000,000.00 
$883,838.00 
Equity 
1
2008-09-05 
$10,846,000.00 
$11,250,000.00 
$404,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
FRANKLIN 
M. 
BERGER 
DIRECTOR
SEATTLE GENETICS INC /WA   |  BIOTIME INC   |  TOCAGEN INC   |  WALKING FISH THERAPEUTICS, INC.
DENNIS 
 
BERMAN 
EXECUTIVE OFFICER, DIRECTOR
TOCAGEN INC   |  INHIBIKASE THERAPEUTICS, INC.
SCOTT 
 
BRUN 
DIRECTOR
FORTE BIOSCIENCES, INC.
HUBERT 
 
CHEN 
EXECUTIVE OFFICER
ARMENIA SDC, LLC   |  JAX SDC, LLC   |  SOUTH BAY DUNN SDC, LLC   |  FORTE BIOSCIENCES, INC.
THOMAS 
 
DARCY 
EXECUTIVE OFFICER, DIRECTOR
TOCAGEN INC
STEPHEN 
 
DOBERSTEIN 
DIRECTOR
FORTE BIOSCIENCES, INC.   |  INVEA THERAPEUTICS, INC
MARTIN 
J 
DUVALL 
EXECUTIVE OFFICER, DIRECTOR
TOCAGEN INC
LAWRENCE 
 
EICHENFIELD 
DIRECTOR
FORTE BIOSCIENCES, INC.   |  FORTE BIOSCIENCES, INC.   |  VERRICA PHARMACEUTICALS INC.
BARBARA 
 
FINK 
DIRECTOR
FORTE BIOSCIENCES, INC.
MARK 
 
FOLETTA 
EXECUTIVE OFFICER
BIOCEPT INC   |  DEXCOM INC   |  TOCAGEN INC
HARRY 
 
GRUBER 
EXECUTIVE OFFICER, DIRECTOR
TOCAGEN INC
DAVID 
 
GRYSKA 
DIRECTOR
HYPERION THERAPEUTICS INC   |  ARGOS THERAPEUTICS INC   |  AERIE PHARMACEUTICALS INC   |  FORTE BIOSCIENCES, INC.   |  MIND MEDICINE (MINDMED) INC.
FAHEEM 
 
HASNAIN 
DIRECTOR
SENTE INC   |  AMBIT BIOSCIENCES CORP   |  RECEPTOS, INC.   |  ARAGON PHARMACEUTICALS, INC.   |  TOCAGEN INC   |  WINDSOR BOYS RACING, LLC   |  GOSSAMER BIO, INC.   |  KURA ONCOLOGY, INC.
DOUGLAS 
 
JOLLY 
EXECUTIVE OFFICER
TOCAGEN INC
STEVEN 
 
KORNFELD 
DIRECTOR
FORTE BIOSCIENCES, INC.
LORI 
 
KUNKEL 
DIRECTOR
TOCAGEN INC   |  MAVERICK THERAPEUTICS INC.   |  NURIX THERAPEUTICS, INC.   |  ORIC PHARMACEUTICALS, INC.
DAVID 
R. 
PARKINSON 
DIRECTOR
TOCAGEN INC   |  CERULEAN PHARMA INC.
ANTONY 
 
RILEY 
EXECUTIVE OFFICER
FORTE BIOSCIENCES, INC.   |  FORTE BIOSCIENCES, INC.
PAUL 
R. 
SCHIMMEL 
DIRECTOR
TOCAGEN INC
PAUL 
 
WAGNER 
EXECUTIVE OFFICER, DIRECTOR
FLY MEDIA, INC.   |  CLOUDENGAGE, INC.   |  FORTE BIOSCIENCES, INC.   |  FORTE BIOSCIENCES, INC.
DONALD 
 
WILLIAMS 
DIRECTOR
MIRENCO INC   |  ALPHATEC HOLDINGS, INC.   |  AKARI THERAPEUTICS PLC   |  PALISADE BIO, INC.   |  FORTE BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-08-09
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2023-07-31 
2017-03-13
D/A
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-11-21 
2016-12-06
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Debt 
2016-11-21 
2015-10-22
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-20 
2015-08-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-20 
2014-07-03
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-20 
2013-06-10
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-05-20 
2012-12-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-21 
2012-03-07
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2012-02-21 
2011-11-08
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-20 
2011-02-16
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-20 
2011-01-04
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-12-20 
2010-10-05
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-30 
2010-07-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-30 
2010-03-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-02-02 
2010-02-26
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-27 
2009-11-23
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-12 
2009-06-18
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-12 
2009-06-02
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-05 
2009-05-15
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-05 
2009-04-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2008-09-05 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NEWBRIDGE SECURITIES CORPORATION
104065
NONE
NONE
SKYWAY ADVISORS, LLC
124630
NONE
NONE
YORAM KINBERG, YK CONSULTING
NONE